Literature DB >> 17988366

Creatine monohydrate in resistant depression: a preliminary study.

Suzana Roitman1, Tamar Green, Yamima Osher, Nathan Karni, Joseph Levine.   

Abstract

OBJECTIVES: Creatine plays a pivotal role in brain energy homeostasis, and altered cerebral energy metabolism may be involved in the pathophysiology of depression. Oral creatine supplementation may modify brain high-energy phosphate metabolism in depressed subjects.
METHODS: Eight unipolar and two bipolar patients with treatment-resistant depression were treated for four weeks with 3-5 g/day of creatine monohydrate in an open add-on design. Outcome measures were the Hamilton Depression Rating Scale, Hamilton Anxiety Scale, and Clinical Global Impression scores, recorded at baseline and at weeks 1, 2, 3 and 4.
RESULTS: One patient improved considerably after one week and withdrew. Both bipolar patients developed hypomania/mania. For the remaining seven patients, all scale scores significantly improved. Adverse reactions were mild and transitory.
CONCLUSIONS: This small, preliminary, open study of creatine monohydrate suggests a beneficial effect of creatine augmentation in unipolar depression, but possible precipitation of a manic switch in bipolar depression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988366     DOI: 10.1111/j.1399-5618.2007.00532.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  37 in total

Review 1.  New therapeutic targets for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Nancy DiazGranados; Lobna Ibrahim; David Latov; Cristina Wheeler-Castillo; Jacqueline Baumann; Ioline D Henter; Carlos A Zarate
Journal:  ScientificWorldJournal       Date:  2010-04-13

Review 2.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

3.  Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Pharmacol Biochem Behav       Date:  2012-03-10       Impact factor: 3.533

4.  Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.

Authors:  Iris Crespo; Alicia Santos; Beatriz Gómez-Ansón; Olga López-Mourelo; Patricia Pires; Yolanda Vives-Gilabert; Susan M Webb; Eugenia Resmini
Journal:  Endocrine       Date:  2016-04-21       Impact factor: 3.633

5.  Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine.

Authors:  Mauricio P Cunha; Josiane Budni; Fabiana K Ludka; Francis L Pazini; Julia Macedo Rosa; Ágatha Oliveira; Mark W Lopes; Carla I Tasca; Rodrigo B Leal; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2015-05-06       Impact factor: 5.590

Review 6.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

7.  Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.

Authors:  Mauricio P Cunha; Francis L Pazini; Julia M Rosa; Ana B Ramos-Hryb; Ágatha Oliveira; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2015-02-22       Impact factor: 3.765

Review 8.  Options for pharmacological treatment of refractory bipolar depression.

Authors:  Leonardo Tondo; Gustavo H Vázquez; Ross J Baldessarini
Journal:  Curr Psychiatry Rep       Date:  2014-02       Impact factor: 5.285

9.  Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder.

Authors:  J Ernst; A Hock; A Henning; E Seifritz; H Boeker; S Grimm
Journal:  Mol Psychiatry       Date:  2016-05-17       Impact factor: 15.992

10.  Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.